Dtsch Med Wochenschr 2008; 133(30): 1578
DOI: 10.1055/s-2008-1081113
Pro & Contra | Commentary
Hepatologie
© Georg Thieme Verlag KG Stuttgart · New York

Resektion versus Ablation beim hepatozellulären Karzinom: pro Ablation

Resection or ablation in hepatocellular carcinoma: pro ablationH. C. Spangenberg1
  • 1Abteilung Innere Medizin II, Universitätsklinik Freiburg
Further Information

Publication History

Publication Date:
18 July 2008 (online)

Literatur

  • 1 Chen M S, Li J Q, Zheng Y. et al . A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma.  Ann Surg. 2006;  243 (3) 321-8
  • 2 Cheng B Q, Jia C Q, Liu C T. et al . Chemoembolization combined with radiofrequency ablation for patients with hepatocellular carcinoma larger than 3 cm: a randomized controlled trial.  J Am Med Assoc. 2008;  299 1669-1677
  • 3 Huang G T, Lee PH, Tsang Y M. et al . Percutaneous ethanol injection versus surgical resection for the treatment of small hepatocellular carcinoma: a prospective study.  Ann Surg. 2005;  242 36-42
  • 4 Lencioni R, Crocetti L. A critical appraisal of the literature on local ablative therapies for hepatocellular carcinoma.  Clin Liver Dis. 2005;  9 301-314
  • 5 Livraghi T, Meloni F, Di Stasi M. et al . Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice?.  Hepatology. 2008;  47 82-89
  • 6 Lopez P M, Villanueva A, Llovet J M. Systematic review: evidence-based management of hepatocellular carcinoma.  Aliment Pharmacol Ther. 2006;  23 1535-1547

PD Dr. H. C. Spangenberg

Abteilung Innere Medizin II, Universitätsklinik Freiburg

Hugstetter Str. 55

79106 Freiburg

Email: hans.spangenberg@uniklinik-freiburg.de

    >